Breast Implant Market to grow at a CAGR of 5.8% by 2025, Driven by Increasing Prevalence of Breast Cancer - Technavio

For more highlights on the parent market analysis -Request a FREE Sample Now!

• Market Driver - The key driver for the breast implant market is the increasing prevalence of breast cancer. Globally, the incidence rate of breast cancer was 0.03 per 100,000 people in 2018. Breast cancer accounts for 1 in 4 cases of cancer diagnosed in women across the world. In 2020, breast cancer accounted for 24.5% of the total new cases of cancer in women. The number of people with breast cancer is constantly increasing. Factors such as family history, age, obesity, breast density, high alcohol consumption, exposure to estrogen, radiation therapy, and hormone replacement therapy treatments are increasing the number of breast cancer cases. According to OECD data, breast cancer is the second most common cause of mortality among women across the OECD countries, accounting for 7.2% of the total cancer mortality rates in 2018. Due to the increasing prevalence of breast cancer, a large number of women are undergoing mastectomy during the breast treatment procedure. As breast implants are used in breast cancer patients after mastectomy for breast reconstruction, the increasing prevalence of breast cancer drives the growth of the global breast implants market.
  
  
• Market Challenges - The key challenge for the breast implant market is the complications associated with the use of breast implants. Some of the post-surgical complications associated with the use of breast implants are the requirement of additional surgeries, development of BIA-ALCL, capsular contracture, silent rupture or leakage of implants, infection, and pain. In addition, chest wall deformity, calcium deposits forming hard lumps under the skin, breast tissue atrophy, extrusion, hematoma, necrosis, bruising, nipple/breast sensation changes, seroma, wrinkling, rippling of implant, and skin rashes are associated with the use of breast implants. The re-operation rate is more among women implanted with silicone breast implants when compared with saline breast implants. Some of the other concerns associated with the use of breast implants include inadequate milk supply for breastfeeding; the high occurrence of platinum toxic material in baby blood breastfeeds after breast implantation; and occurrence of neurological symptoms such as memory loss, difficulties with concentration, and other cognitive problems. Such complications are expected to hinder the market growth during the forecast period.

To learn about additional key drivers, trends, and challenges - Request a FREE Sample Report right now!

The breast implant market report is segmented by Product (Silicone breast implants and Saline breast implants), Application (Breast cosmetic surgery and Breast reconstruction surgery), and Geography (North America, Europe, Asia, and ROW). 

Revenue Generating Segment - The breast implant market share growth in the silicone breast implants segment will be significant for revenue generation. Breast implants filled with silicone gel are often firm, pliable, and lightweight with a natural appearance.

Grab a sample report for additional insights into the contribution of all the segments

The breast implant market is fragmented and the vendors are deploying growth strategies such as organic and inorganic strategies to compete in the market.

• AbbVie Inc.
• CEREPLAS Co.
• Establishment Labs Holdings Inc.
• GC Aesthetics Inc.
• Groupe SEBBIN SAS
• Ideal Implant Inc.
• Johnson and Johnson Inc.
• Laboratories Arion
• POLYTECH Health & Aesthetics GmbH
• Sientra Inc.
• To gain access to more vendor profiles with their key offerings available with Technavio, Click Here

The competitive scenario provided in the Breast Implant Market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc. Don't wait, Make a strategic approach & boost your business goals with our Breast Implant Market Forecast Report -  Buy Now!

• The cardiology electrodes market share is expected to increase to USD 95.68 million from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 4.52%.
• The veterinary endoscopy devices market share is expected to increase to USD 121.34 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.69%.

Browse for Technavio "Healthcare Market" Research Reports

1 Executive Summary

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 01: Parent market
• Exhibit 02: Market characteristics

• 2.2 Value chain analysis
• Exhibit 03:Value chain analysis - Healthcare equipment

3 Market Sizing

• 3.1 Market definition
• Exhibit 04: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
• Exhibit 05: Market segments

• 3.3 Market size 2020

• 3.4 Market outlook: Forecast for 2020 - 2025
• Exhibit 06: Global - Market size and forecast 2020 - 2025 ($ million)
• Exhibit 07: Global market: Year-over-year growth 2020 - 2025 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 08: Five forces analysis 2020 & 2025

• 4.2 Bargaining power of buyers
• Exhibit 09: Bargaining power of buyers

• 4.3 Bargaining power of suppliers
• Exhibit 10: Bargaining power of suppliers

• 4.4 Threat of new entrants
• Exhibit 11: Threat of new entrants

• 4.5 Threat of substitutes
• Exhibit 12: Threat of substitutes

• 4.6 Threat of rivalry
• Exhibit 13: Threat of rivalry

• 4.7 Market condition
• Exhibit 14: Market condition - Five forces 2020

5 Market Segmentation by Product

• 5.1 Market segments
• Exhibit 15: Product - Market share 2020-2025 (%)

• 5.2 Comparison by Product
• Exhibit 16: Comparison by Product

• 5.3 Silicone breast implants - Market size and forecast 2020-2025
• Exhibit 17: Silicone breast implants - Market size and forecast 2020-2025 ($ million)
• Exhibit 18: Silicone breast implants - Year-over-year growth 2020-2025 (%)

• 5.4 Saline breast implants - Market size and forecast 2020-2025
• Exhibit 19: Saline breast implants - Market size and forecast 2020-2025 ($ million)
• Exhibit 20: Saline breast implants - Year-over-year growth 2020-2025 (%)

• 5.5 Market opportunity by Product
• Exhibit 21: Market opportunity by Product

6 Market Segmentation by Application

• 6.1 Market segments
• Exhibit 22: Application - Market share 2020-2025 (%)

• 6.2 Comparison by Application
• Exhibit 23: Comparison by Application

• 6.3 Breast cosmetic surgery - Market size and forecast 2020-2025
• Exhibit 24: Breast cosmetic surgery - Market size and forecast 2020-2025 ($ million)
• Exhibit 25: Breast cosmetic surgery - Year-over-year growth 2020-2025 (%)

• 6.4 Breast reconstruction surgery - Market size and forecast 2020-2025
• Exhibit 26: Breast reconstruction surgery - Market size and forecast 2020-2025 ($ million)
• Exhibit 27: Breast reconstruction surgery - Year-over-year growth 2020-2025 (%)

• 6.5 Market opportunity by Application
• Exhibit 28: Market opportunity by Application

7 Customer landscape

8 Geographic Landscape

• 8.1 Geographic segmentation
• Exhibit 30: Market share by geography 2020-2025 (%)

• 8.2 Geographic comparison
• Exhibit 31: Geographic comparison

• 8.3 North America - Market size and forecast 2020-2025
• Exhibit 32: North America - Market size and forecast 2020-2025 ($ million)
• Exhibit 33: North America - Year-over-year growth 2020-2025 (%)

• 8.4 Europe - Market size and forecast 2020-2025
• Exhibit 34: Europe - Market size and forecast 2020-2025 ($ million)
• Exhibit 35: Europe - Year-over-year growth 2020-2025 (%)

• 8.5 Asia - Market size and forecast 2020-2025
• Exhibit 36: Asia - Market size and forecast 2020-2025 ($ million)
• Exhibit 37: Asia - Year-over-year growth 2020-2025 (%)

• 8.6 ROW - Market size and forecast 2020-2025
• Exhibit 38: ROW - Market size and forecast 2020-2025 ($ million)
• Exhibit 39: ROW - Year-over-year growth 2020-2025 (%)

• 8.7 Key leading countries
• Exhibit 40: Key leading countries

• 8.8 Market opportunity by geography
• Exhibit 41: Market opportunity by geography ($ million)

9 Drivers, Challenges, and Trends

• 9.1 Market drivers

• 9.2 Market challenges
• Exhibit 42: Impact of drivers and challenges

• 9.3 Market trends

10 Vendor Landscape

• 10.1 Overview

• 10.2 Vendor landscape
• Exhibit 43: Vendor landscape

• 10.3 Landscape disruption
• Exhibit 44: Landscape disruption
• Exhibit 45: Industry risks

11 Vendor Analysis

• 11.1 Vendors covered
• Exhibit 46: Vendors covered

• 11.2 Market positioning of vendors
• Exhibit 47: Market positioning of vendors

• 11.3 AbbVie Inc.
• Exhibit 48: AbbVie Inc. - Overview
• Exhibit 49: AbbVie Inc. - Product and service
• Exhibit 50: AbbVie Inc. – Key news
• Exhibit 51: AbbVie Inc. - Key offerings

• 11.4 CEREPLAS Co.
• Exhibit 52: CEREPLAS Co. - Overview
• Exhibit 53: CEREPLAS Co. - Product and service
• Exhibit 54: CEREPLAS Co. - Key offerings

• 11.5 Establishment Labs Holdings Inc.
• Exhibit 55: Establishment Labs Holdings Inc. - Overview
• Exhibit 56: Establishment Labs Holdings Inc. - Product and service
• Exhibit 57: Establishment Labs Holdings Inc. – Key news
• Exhibit 58: Establishment Labs Holdings Inc. - Key offerings

• 11.6 GC Aesthetics Inc.
• Exhibit 59: GC Aesthetics Inc. - Overview
• Exhibit 60: GC Aesthetics Inc. - Product and service
• Exhibit 61: GC Aesthetics Inc. – Key news
• Exhibit 62: GC Aesthetics Inc. - Key offerings

• 11.7 Groupe SEBBIN SAS
• Exhibit 63: Groupe SEBBIN SAS - Overview
• Exhibit 64: Groupe SEBBIN SAS - Product and service
• Exhibit 65: Groupe SEBBIN SAS - Key offerings

• 11.8 Ideal Implant Inc.
• Exhibit 66: Ideal Implant Inc. - Overview
• Exhibit 67: Ideal Implant Inc. - Product and service
• Exhibit 68: Ideal Implant Inc. - Key offerings

• 11.9 Johnson and Johnson Inc.
• Exhibit 69: Johnson and Johnson Inc. - Overview
• Exhibit 70: Johnson and Johnson Inc. - Business segments
• Exhibit 71: Johnson and Johnson Inc. – Key news
• Exhibit 72: Johnson and Johnson Inc. - Key offerings
• Exhibit 73: Johnson and Johnson Inc. - Segment focus

• 11.10 Laboratories Arion
• Exhibit 74: Laboratories Arion - Overview
• Exhibit 75: Laboratories Arion - Product and service
• Exhibit 76: Laboratories Arion - Key offerings

• 11.11 POLYTECH Health & Aesthetics GmbH
• Exhibit 77: POLYTECH Health & Aesthetics GmbH - Overview
• Exhibit 78: POLYTECH Health & Aesthetics GmbH - Product and service
• Exhibit 79: POLYTECH Health & Aesthetics GmbH - Key offerings

• 11.12 Sientra Inc.
• Exhibit 80: Sientra Inc. - Overview
• Exhibit 81: Sientra Inc. - Business segments
• Exhibit 82: Sientra Inc. – Key news
• Exhibit 83: Sientra Inc. - Key offerings
• Exhibit 84: Sientra Inc. - Segment focus

12 Appendix

• 12.1 Scope of the report

• 12.2 Currency conversion rates for US$
• Exhibit 85: Currency conversion rates for US$

• 12.3 Research methodology
• Exhibit 86: Research Methodology
• Exhibit 87: Validation techniques employed for market sizing
• Exhibit 88: Information sources

• 12.4 List of abbreviations
• Exhibit 89: List of abbreviations

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email:[email protected]
Website: www.technavio.com/

SOURCE Technavio